Trial Profile
Prospective, randomized, open-label, parallel study investigating safety and efficacy of adding liraglutide, saxagliptin and vildagliptin to current antidiabetic therapy in chinese patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Saxagliptin (Primary) ; Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 31 Oct 2015 New trial record